Corporate Overview
Etico Lifesciences Private Limited is a premier Contract Development & Manufacturing Organization (CDMO) incorporated in 2016. We specialize in the development of niche generic and specialty pharmaceutical products with a strong focus on clinical excellence.
Our operation is anchored by a multidisciplined team of 90+ professionals possessing an excellent track record in complex molecules. We hold specialized permits from regulatory authorities to work with Narcotics, Psychotropic, and Controlled substances for research purposes.
Partner With Us
Evolution & Milestones
2016
Incorporation of Etico Lifesciences.
2017
Signed our First Licensing Agreement.
2019
Launched Stand-alone Advanced Analytical Services.
2020
Established full OSD (Oral Solid Dosage) Capability.
2022
Achievement of our first ANDA approval.
2023
First Peptide Out-licensing with Profit Share milestone.
2024
Clinical success with successful Pre-IND for 2 products.
2025
Targeted successful Pre-IND for our primary specialty product.
Global Strategic Partnerships
Serving esteemed clients across the most highly regulated global markets:
United States
European Union
United Kingdom
Canada
Australia
GCC Region
Our Certifications
ISO
Certified
DSIR
Recognized
GLP
Compliant
DCA
Accredited
Compliance with international ICH and regulatory safety standards.